INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand building
News provided by
Share this article
SARASOTA, Fla., April 26, 2021 /PRNewswire/ --
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Rebecca Messina to the Company's board of directors, effective immediately.
Messina has broad international experience in leading marketing for elite brands and businesses including Uber, Beam Suntory and The Coca-Cola Company. She is currently a Senior Advisor at McKinsey & Company focused on advising internal teams and firm clients in the areas of marketing as a growth lever, including data driven marketing, brand building, and strategically shaping and transforming marketing agendas.